260 related articles for article (PubMed ID: 17785321)
1. Performance of antinuclear antibody connective tissue disease screen.
López-Hoyos M; Rodríguez-Valverde V; Martinez-Taboada V
Ann N Y Acad Sci; 2007 Aug; 1109():322-9. PubMed ID: 17785321
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the LIAISON ANA screen assay for antinuclear antibody testing in autoimmune diseases.
Ghillani P; Rouquette AM; Desgruelles C; Hauguel N; Le Pendeven C; Piette JC; Musset L
Ann N Y Acad Sci; 2007 Aug; 1109():407-13. PubMed ID: 17785329
[TBL] [Abstract][Full Text] [Related]
3. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM
Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of antinuclear antibodies in connective tissue disease.
Pahor A; Krajnc I; Gorenjak M; Holc I
Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
[TBL] [Abstract][Full Text] [Related]
5. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay.
Op De Beeck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
Autoimmun Rev; 2011 Oct; 10(12):801-8. PubMed ID: 21741497
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of anti-ribosomal P protein immunoassay in Japanese patients with connective tissue diseases: comparison with an indirect immunofluorescence assay.
Muro Y; Sugiura K; Morita Y; Tomita Y
Scand J Rheumatol; 2009; 38(6):460-3. PubMed ID: 19922022
[TBL] [Abstract][Full Text] [Related]
7. [Performance and clinical evaluation of antinuclear antibody test based on fluorescence enzyme immunoassay].
Watanabe N; Nagatomo R; Okubo S; Yokota H; Ikeda H; Yatomi Y
Rinsho Byori; 2014 Apr; 62(4):315-23. PubMed ID: 25022060
[TBL] [Abstract][Full Text] [Related]
8. Detection of anti-nuclear antibodies from filter paper blood clots using indirect immunoenzyme technique: preliminary experience and results.
Chopra A; Anuradha V; Edmonds J
J Assoc Physicians India; 2000 May; 48(5):493-6. PubMed ID: 11273141
[TBL] [Abstract][Full Text] [Related]
9. Understanding antinuclear antibodies.
Pertusi RM; Rubin BR
J Am Osteopath Assoc; 1991 Jun; 91(6):563-4, 567-9. PubMed ID: 1874653
[TBL] [Abstract][Full Text] [Related]
10. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
Vos PA; Bast EJ; Derksen RH
Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
[TBL] [Abstract][Full Text] [Related]
11. [Use of autoantibodies in clinical practice].
Petitpierre S; Aubert V; Leimgruber A; Spertini F; Bart PA
Rev Med Suisse; 2009 Apr; 5(199):823-31. PubMed ID: 19441748
[TBL] [Abstract][Full Text] [Related]
12. [Detection of anti-SSA/Ro antibody by ELISA, double immunodiffusion, and immunoblotting: a comparative study].
Tong SQ; Shi Q; Wen XH; Gan XD; Shi YP; Zhao Y; Zeng XF; Zhang FC; Dong Y
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2455-7. PubMed ID: 17156670
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of indirect immunofluorescence and enzyme immunoassay methods for the determination of antinuclear antibodies].
Yilmaz O; Karaman M; Ergon MC; Bahar IH; Yuluğ N
Mikrobiyol Bul; 2004; 38(1-2):85-90. PubMed ID: 15293906
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Screening Dilution and Automated Reading for Antinuclear Antibody Detection on HEP2 Cells in the Monitoring of Connective Tissue Diseases.
Depincé-Berger AE; Moreau A; Bossy V; Genin C; Rinaudo M; Paul S
J Clin Lab Anal; 2016 Sep; 30(5):471-8. PubMed ID: 27225012
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of simultaneous detection of specific antinuclear antibodies using multiplexed technology].
Uto K; Hayashi N; Kinoshita S; Kawano S; Kumagai S
Rinsho Byori; 2009 Oct; 57(10):941-53. PubMed ID: 19928490
[TBL] [Abstract][Full Text] [Related]
16. Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases.
Eissfeller P; Sticherling M; Scholz D; Hennig K; Lüttich T; Motz M; Kromminga A
Ann N Y Acad Sci; 2005 Jun; 1050():327-39. PubMed ID: 16014549
[TBL] [Abstract][Full Text] [Related]
17. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
Myckatyn SO; Russell AS
J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence and diagnostic value of antinuclear antibodies without identified antigenic target: a retrospective study of 90 patients].
Feki S; Frikha F; Ben Hadj Hmida Y; Abed S; Ben Ayed M; Turki H; Hachicha J; Baklouti S; Bahloul Z; Masmoudi H
Rev Med Interne; 2012 Sep; 33(9):475-81. PubMed ID: 22658165
[TBL] [Abstract][Full Text] [Related]
19. Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.
Lee H; Kim Y; Han K; Oh EJ
Scand J Rheumatol; 2016; 45(2):122-8. PubMed ID: 26643611
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods.
Desplat-Jego S; Bardin N; Larida B; Sanmarco M
Ann N Y Acad Sci; 2007 Aug; 1109():245-55. PubMed ID: 17785313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
